News bites: Cord blood, Wal-Mart and more

The FDA approved the first umbilical cord blood product. Hemacord is indicated for use in hematopoietic (blood-forming) stem cell transplantation procedures in patients with disorders affecting the hematopoietic system.

Wal-Mart walked back its stated commitment to building a "national, integrated, low-cost primary care healthcare platform that will provide preventative and chronic care services that are currently out of reach for millions of Americans," Kaiser Health News reports.

A New Jersey couple credits Gov. Chris Christie's new mandate on pulse oximetry heart scans for newborns with saving their baby's life, the Newark Star-Ledger reports.

The National Association of Medicaid Directors is demanding more flexibility in a new report.

A Kansas judge dismissed 23 felony charges against Planned Parenthood, the Kansas City Star reports.